Bridgewest ATROPINE INJECTION BP atropine sulfate monohydrate 1200 microgram/1 mL injection BP ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest atropine injection bp atropine sulfate monohydrate 1200 microgram/1 ml injection bp ampoule

bridgewest perth pharma pty ltd - atropine sulfate monohydrate, quantity: 1.2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - indications as at 23 october 2001: preanaesthetic medication to reduce salivary secretions and bronchial secretions. to prevent cholinergic cardiac effects such as cardiac arrhythmias, hypotension and bradycardia. management of patients with acute myocardial infarction and sinus bradycardia who have associated hypotension and increased ventricular irritability. concurrent administration with anticholinesterase agents (eg. neostigmine, physostigmine) to block the adverse muscarinic effects of these agents following surgery to terminate curarisation. for poisoning by organophosphate pesticides, atropine may be used concomitantly with a cholinesterase reactivator such as pralidoxime to reverse muscarinic effects.

Bridgewest ATROPINE INJECTION BP atropine sulfate monohydrate 600 microgram/1 mL injection BP ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest atropine injection bp atropine sulfate monohydrate 600 microgram/1 ml injection bp ampoule

bridgewest perth pharma pty ltd - atropine sulfate monohydrate, quantity: 600 microgram/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - indications as at 23 october 2001: preanaesthetic medication to reduce salivary secretions and bronchial secretions. to prevent cholinergic cardiac effects such as cardiac arrhythmias, hypotension and bradycardia. management of patients with acute myocardial infarction and sinus bradycardia who have associated hypotension and increased ventricular irritability. concurrent administration with anticholinesterase agents (eg. neostigmine, physostigmine) to block the adverse muscarinic effects of these agents following surgery to terminate curarisation. for poisoning by organophosphate pesticides, atropine may be used concomitantly with a cholinesterase reactivator such as pralidoxime to reverse muscarinic effects.

Minims Cyclopentolate Hydrochloride 1% w/v Eye Drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

minims cyclopentolate hydrochloride 1% w/v eye drops, solution

bausch + lomb ireland limited - cyclopentolate hydrochloride - eye drops, solution - anticholinergics; cyclopentolate

ATROPINE JUNO atropine sulfate monohydrate 600 microgram/1mL injection BP ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

atropine juno atropine sulfate monohydrate 600 microgram/1ml injection bp ampoule

juno pharmaceuticals pty ltd - atropine sulfate monohydrate, quantity: 600 microgram/ml; sodium hydroxide - injection, solution - excipient ingredients: water for injections; sodium chloride; sulfuric acid - indications as at 30 september 2003:surgery : atropine may be given as a pre-anaesthetic medication to inhibit excessive salivary and bronchial secretions and to diminish the risk of vagal inhibition of the heart. the use of atropine as an antisialogogue is rarely necessary since the introduction of halothane and similar anaesthetics in place of ether anaesthesia. after surgery atropine may also be administered concurrently with anticholinesterase agents (e.g. neostigmine, physostigmine) when used to terminate curarisation to counteract the adverse muscarinic effects of these drugs. cardiopulmonary resuscitation : atropine may be used during cardiopulmonary resuscitation to treat sinus bradycardia and associated hypotension, and increased ventricular irritability. anticholinesterase poisoning : atropine juno is also used in the treatment of sinus bradycardia induced by organophosphate pesticides, amanita muscaria mushrooms or other compounds with anticholinesterase activity. a cholinesterase reactivator, e.g. pralidoxime iodide, may be given concurrently.

Bisoprolol Zentiva 1.25mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

bisoprolol zentiva 1.25mg tablets

zentiva k.s. - bisoprolol fumarate - tablet - bisoprolol

Bisoprolol Zentiva 10 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

bisoprolol zentiva 10 mg tablets

zentiva k.s. - bisoprolol fumarate - tablet - bisoprolol

Bisoprolol Zentiva 2.5mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

bisoprolol zentiva 2.5mg tablets

zentiva k.s. - bisoprolol fumarate - tablet - bisoprolol

Bisoprolol Zentiva 3.75mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

bisoprolol zentiva 3.75mg tablets

zentiva k.s. - bisoprolol fumarate - tablet - bisoprolol

Bisoprolol Zentiva 5mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

bisoprolol zentiva 5mg tablets

zentiva k.s. - bisoprolol fumarate - tablet - bisoprolol

Bisoprolol Zentiva 7.5mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

bisoprolol zentiva 7.5mg tablets

zentiva k.s. - bisoprolol fumarate - tablet - bisoprolol